Microsoft says its customers can still access Anthropic products after supply chain risk designation

Microsoft says its customers can still access Anthropic products after supply chain risk designation


Microsoft CEO Satya Nadella speaks at the Microsoft AI Tour event in Munich, Germany, on Feb. 25, 2026

Sven Hoppe | Picture Alliance | Getty Images

Microsoft said Thursday that it will keep startup Anthropic’s artificial intelligence technology embedded in its products for clients, excluding the U.S. Department of War.

Earlier on Thursday, the federal agency informed Anthropic that it would label the company a supply-chain risk. Anthropic subsequently said it intends to challenge the move in court.

Last week U.S. President Donald Trump called for federal agencies to drop their use of Anthropic, and Secretary of War Pete Hegseth said Anthropic would keep providing its services to the Pentagon for no more than six months. CNBC has confirmed that Anthropic models played a role in U.S. airstrikes on Iran in recent days.

Microsoft is the first major company to say it will keep working with Anthropic after the Pentagon’s actions.

“Our lawyers have studied the designation and have concluded that Anthropic products, including Claude, can remain available to our customers — other than the Department of War — through platforms such as M365, GitHub, and Microsoft’s AI Foundry and that we can continue to work with Anthropic on non-defense related projects,” a Microsoft spokesperson told CNBC in an email.

Microsoft supplies its technology to a variety of U.S. government agencies. The Microsoft 365 productivity software is widely used inside the Department of War. In September Microsoft said it was integrating Anthropic’s generative artificial intelligence models into the Microsoft 365 Copilot add-on for Microsoft 365 subscriptions, alongside models from OpenAI.

Many software engineers have adopted Anthropic’s Claude models for drafting source code, and they are available inside GitHub Copilot, as are OpenAI’s competing Codex models.

Microsoft CEO Satya Nadella initially sought to invest in and work closely with OpenAI. More recently, Nadella has made AI models from other developers available in Microsoft products.

“Model choice!” Nadella wrote in an October X post showing off the abiltiy to toggle between Anthropic and OpenAI models in Microsoft 365 Copilot.

In November, Microsoft said Anthropic has committed to spending $30 billion on Microsoft’s Azure cloud services, while Microsoft agreed to invest up to $5 billion in Anthropic. The numbers are larger for Microsoft’s OpenAI partnership. As of October, Microsoft held a $135 billion stake in OpenAI’s public benefit corporation, and OpenAI was committing to spend $250 billion on Azure.

This is developing news. Please check back for updates.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source

We spoke to over 30 CEOs and business leaders. Here’s what worries them most
World

We spoke to over 30 CEOs and business leaders. Here’s what worries them most

Business leaders are confronting a new operating reality: one where war, inflation, AI and supply chain shocks are no longer exceptional events, but part of the baseline. CNBC spoke to more than 30 CEOs, business executives and industry leaders at the annual Converge Live event in Singapore last week. Across sectors — banking, energy, shipping, […]

Read More
U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets
World

U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets

A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 16, 2026. Jeenah Moon | Reuters Global markets are entering the week balancing resilient risk appetite against renewed geopolitical strain as prospects of U.S.-Iran negotiations took a hit over the weekend. U.S. President Donald Trump scrapped […]

Read More
Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in .75 billion deal
World

Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

SHANGHAI, CHINA – NOVEMBER 05: People visit the booth of Organon during the 7th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November 5, 2024 in Shanghai, China. The 7th China International Import Expo (CIIE) kicked off in Shanghai on November 5. (Photo by Tang Yanjun/China News Service/VCG via […]

Read More